A number of 4-amino-5-vinylpyridazinones and 4-amino-5-heterocyclic-pyridazinones were synthesized and tested for their analgesic activity. Many of these compounds, tested at doses of 3-20 mg kg-1 po, showed good antinociceptive activity, reducing by more than 50% the number of writhes with respect to controls. Compounds 16c, 19a, 20a, and 28 were the most potent of the series because they were able to induce a potent antinociceptive effect at a dose of 3 mg kg-1 po. None of the active compounds at the analgesic dose provoked any visible change in normal behavior, as demonstrated in the rotarod test. Studies on the mechanism of action showed that the analgesia induced by the active compounds was completely prevented by pretreatment with the R2-antagonist yohimbine, suggesting an involvement of R2-adrenoceptors. Further investigation demonstrated an indirect activation of the noradrenergic system through an amplification of noradrenaline release.

4-Amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action / M.GIOVANNONI; N.CESARI; C.VERGELLI; A.GRAZIANO; C.BIANCALANI; P.BIAGINI; C.GHELARDINI; E.VIVOLI; V.DAL PIAZ. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - ELETTRONICO. - 50:(2007), pp. 3945-3953. [10.1021/jm070161e]

4-Amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action

GIOVANNONI, MARIA PAOLA;VERGELLI, CLAUDIA;GHELARDINI, CARLA;
2007

Abstract

A number of 4-amino-5-vinylpyridazinones and 4-amino-5-heterocyclic-pyridazinones were synthesized and tested for their analgesic activity. Many of these compounds, tested at doses of 3-20 mg kg-1 po, showed good antinociceptive activity, reducing by more than 50% the number of writhes with respect to controls. Compounds 16c, 19a, 20a, and 28 were the most potent of the series because they were able to induce a potent antinociceptive effect at a dose of 3 mg kg-1 po. None of the active compounds at the analgesic dose provoked any visible change in normal behavior, as demonstrated in the rotarod test. Studies on the mechanism of action showed that the analgesia induced by the active compounds was completely prevented by pretreatment with the R2-antagonist yohimbine, suggesting an involvement of R2-adrenoceptors. Further investigation demonstrated an indirect activation of the noradrenergic system through an amplification of noradrenaline release.
2007
50
3945
3953
M.GIOVANNONI; N.CESARI; C.VERGELLI; A.GRAZIANO; C.BIANCALANI; P.BIAGINI; C.GHELARDINI; E.VIVOLI; V.DAL PIAZ
File in questo prodotto:
File Dimensione Formato  
316689 JMC 2007.pdf

Accesso chiuso

Tipologia: Altro
Licenza: DRM non definito
Dimensione 133.31 kB
Formato Adobe PDF
133.31 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/316689
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 24
social impact